Zanubrutinib (Brukinsa): CADTH Reimbursement Review [Internet]
Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Sep.
CADTH Reimbursement Reviews and Recommendations.
PMID:
38696636
Bookshelf ID:
NBK603333
No abstract available
Copyright © 2022 Canadian Agency for Drugs and Technologies in Health.
Sections
Clinical Review
Pharmacoeconomic Review
Stakeholder Input
Publication types
Review